Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Surgical oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0960-7404(93)90044-YPMID 8252193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction

  2005cited by this paper
• Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content

  2005cited by this paper
• C‐erbb‐2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node‐positive breast cancer

  1992cited by this paper
• Staging of breast cancer.

  1992cited by this paper
• The role of nucleolar organiser regions as prognostic factors in breast cancer.

  1991cited by this paper
• Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer

  1991cited by this paper
• Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.

  1991cited by this paper
• Prognostic significance of dna‐ploidy in a series of 690 primary breast cancer patients

  1990cited by this paper
• Argyrophilic nuclear organiser region counts in locally advanced breast carcinoma treated by chemotherapy before surgery.

  1990cited by this paper
• Nucleolar organiser regions: new prognostic variable in breast carcinomas.

  1990cited by this paper
• HER-2/neu amplification predicts poor survival in node-positive breast cancer.

  1990cited by this paper
• Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

  1989cited by this paper
• Silver‐binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: Correlations with ploidy and growth phase by DNA flow cytometry

  1989cited by this paper
• Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

  1989cited by this paper
• A controlled trial of extended radical versus radical mastectomy. Ten‐year results

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• HER-2/neu oncogene protein and prognosis in breast cancer.

  1989cited by this paper
• c-erbB-2 expression in benign and malignant breast disease.

  1988cited by this paper
• Silver‐stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma

  1988cited by this paper
• DNA flow cytometry applied to fine needle sampling of human breast cancer

  1988cited by this paper
• Amplification of c-erbB-2 and aggressive human breast tumors?

  1988cited by this paper
• Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

  1988cited by this paper
• Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

  1988cited by this paper
• Evaluation of nucleolar organizer region‐associated proteins in breast malignancy

  1988cited by this paper
• An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.

  1988cited by this paper
• Breast cancer diagnosis.

  1988cited by this paper
• Expression of the c‐erbB‐2 protein in normal and transformed cells

  1987cited by this paper
• Prognosis of breast cancer with axillary node metastases after surgical treatment only.

  1987cited by this paper
• Is it useful to remove internal mammary nodes in operable breast cancer?

  1987cited by this paper
• Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

  1987cited by this paper
• Effect of axillary nodal status on the long‐term survival following mastectomy for breast carcinoma: Nodal metastases may not always suggest systemic disease

  1987cited by this paper
• Nucleolar organizer regions in lymphomas

  1987cited by this paper
• DNA ploidy and survival in breast cancer patients.

  1987cited by this paper
• Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

  1985cited by this paper
• Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.

  1985cited by this paper
• Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.

  1985cited by this paper
• Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary Nodes

  1985cited by this paper
• Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

  1984cited by this paper
• Surgical management of primary breast cancer

  1983cited by this paper
• Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

  1983cited by this paper
• The World Health Organization Histological Typing of Breast Tumors—Second Edition

  1982cited by this paper
• Inefficacy of internal mammary nodes dissection in breast cancer surgery

  1981cited by this paper
• Staging of breast cancer: a new rationale for internal mammary node biopsy.

  1981cited by this paper
• Management and survival of female breast cancer: Results of a national survey by the American college of surgeons

  1980cited by this paper
• Computerized internal mammary lymphoscintigraphy in radiation treatment planning of patients with breast carcinoma.

  1979cited by this paper
• Internal mammary lymphoscintigraphy. The rationale, technique, interpretation and clinical application: a review based on 848 cases.

  1976cited by this paper
• Long‐term followup of breast cancer patients: The 30‐year report

  1974cited by this paper
• CANCER OF THE BREAST

  1941cited by this paper

• Lymph Node Metastasis Status in Breast Carcinoma Can Be Predicted via Image Analysis of Tumor Histology.

  2015cites this paper
• Sentinel Lymph Node Detection in Early Carcinoma Breast : A Comparative Study Between Intralesional and Perilesional Dye Injection

  2015cites this paper
• Predictors of axillary lymph node metastasis in breast cancer: a systematic review.

  2007cites this paper
• Sentinel lymph node biopsy in breast cancer.

  2006cites this paper
• Diagnosis of axillary lymph node metastases in patients with breast cancer

  2005cites this paper
• Intraoperative assessment of axillary lymph node metastases in operable breast cancer

  2005cites this paper
• [Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method].

  2003cites this paper
• Implications of Axillary Sentinel Lymph Node Biopsy in Immediate Autologous Breast Reconstruction

  2002cites this paper
• Axillary Lymph Node Dissection in Breast Cancer: Current Status and Controversies, Alternative Strategies and Future Perspectives

  2000cites this paper
• Role of sentinel lymph node dissection in breast cancer

  2000cites this paper
• Sentinel node biopsy in breast cancer.

  2000cites this paper
• Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer

  2000cites this paper
• Sentinel Lymph Node Biopsy in Breast Cancer

  2000cites this paper
• Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer

  2000cites this paper
• Sentinel node biopsy in breast cancer.

  1999cites this paper
• Sentinel node biopsy in breast cancer.

  1999cites this paper
• Sentinel lymphadenectomy in breast cancer: An alternative to routine axillary dissection

  1998cites this paper
• Axillary clearance in operable breast cancer: still a necessity?

  1998cites this paper
• Sentinel Lymph Node Technique for Staging of Breast Cancer.

  1998cites this paper
• Is Axillary Lymph Node Dissection Necessary in Routine Management of Breast Cancer? No.

  1997cites this paper
• Axillary lymphadenectomy: A diagnostic and therapeutic procedure

  1997cites this paper
• [Preoperative axillary ultrasound in breast carcinoma: value of the method in routine clinical practice].

  1996cites this paper
• Breast-conserving treatment: controversies and consensus.

  1996cites this paper
• Review: Breast‐conserving treatment: Controversies and consensus

  1996cites this paper
• Intraoperative histologic assessment of surgical margins and lymph node metastasis in breast‐conserving surgery

  1995cites this paper
• The surgical management of primary invasive breast cancer

  1995cites this paper
• Breast conservation therapy for invasive carcinoma of the breast.

  1995cites this paper
• Typing and grading breast carcinoma on fine‐needle aspiration: Is this clinically useful information?

  1995cites this paper
• Breast conservation therapy for invasive carcinoma of the breast

  1995cites this paper
• A QC H ANALY TICAL and QUANTITATIVECYTOPATHOLOGY and HISTOPATHOLOGY

  year unknowncites this paper